Euro-area Q3 GDP grows 0.4% in preliminary estimate
Eurostat estimated that euro-area GDP increased 0.4% in Q3, with the wider EU up 0.5%. This is a preliminary flash reading based on incomplete information, not the final national-accounts result.
Eurostat estimated that euro-area GDP increased 0.4% in Q3, with the wider EU up 0.5%. This is a preliminary flash reading based on incomplete information, not the final national-accounts result.
CaixaBank reported €4.96 billion in profit for the first nine months of 2026 and approved a €0.1844 gross-per-share interim dividend. The payment is scheduled for 6 November; the earnings figure is not for Q3 alone.
NatWest reported £1.5 billion in third-quarter attributable profit, alongside 19.3p earnings per share. Its 21.6% return on tangible equity is a bank-performance ratio, not a guaranteed return for shareholders.
AstraZeneca reported 7% third-quarter revenue growth and higher earnings on both reported and core bases. Its unchanged annual outlook is expressed at constant exchange rates, not as a promise of reported profit.
nVent reported quarterly sales of about $1.5 billion and lifted its annual sales and EPS forecasts. Reported diluted EPS was $1.23, compared with adjusted EPS of $1.52. The release presents continuing operations unless otherwise stated.
Sanofi raised its full-year outlook after third-quarter sales grew 16.2% at actual exchange rates. IFRS shareholder profit rose 7.8%; the faster growth in its non-IFRS business earnings needs a separate comparison.
STMicroelectronics increased Q3 revenue to $3.757 billion and reported net income to $291 million. Its $4.15 billion Q4 revenue midpoint is a conditional forecast, not achieved sales.
Santander's Q3 underlying profit reached €3.848 billion, up 19%, while attributable profit fell 2% to €3.432 billion. Its reconciliation explains why the measures diverged.
Unilever reported 5.2% underlying sales growth in Q3 and now expects at least 3% full-year underlying volume growth. Reported turnover growth also includes portfolio and currency effects.
GSK reported £8.887 billion in Q3 sales, up 4% at actual exchange rates. Reported EPS fell 23%, compared with a 1% decline in core EPS, as restructuring affected the results.
BNP Paribas reported third-quarter net income attributable to shareholders of €3.456 billion as revenue increased 9.5%. Its ECB-authorised €1.3 billion share buyback is due to launch in November, not a completed repurchase.
UBS reported US$2.690bn in third-quarter net profit and US$55.1bn of wealth-management inflows. Reported pre-tax profit rose 27%, versus 14% on its underlying basis.
Start with three recent reports, then explore the facts, sources and practical context. No political coverage. No promises of investment returns.
Questions or corrections? Contact the newsroom.